Home About Us Media Kit Subscriptions Links Forum
APPEARED IN


View All Articles

Download PDF

FAMOUS INTERVIEWS

Directories:

SCHOLARSHIPS & GRANTS

HELP WANTED

Tutors

Workshops

Events

Sections:

Books

Camps & Sports

Careers

Children’s Corner

Collected Features

Colleges

Cover Stories

Distance Learning

Editorials

Famous Interviews

Homeschooling

Medical Update

Metro Beat

Movies & Theater

Museums

Music, Art & Dance

Special Education

Spotlight On Schools

Teachers of the Month

Technology

Archives:

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

1995-2000


MAY 2005

The Case for State-Funded
Stem Cell Research
By New Jersey Acting Governor Richard J. Codey

As a society and a government, we have an obligation to help those among us who are suffering. If we have an opportunity to save lives, we must pursue it. Stem cell research is that opportunity. It is our best hope for people who suffer from Alzheimer’s and Parkinson’s, diabetes and stroke, and spinal cord and brain injuries. Opponents say stem cell research takes lives, that any embryo used for stem cell research would have developed into a person. That is just plain wrong. These are embryos that if not for stem cell research would be discarded. Using them to potentially save lives is the morally correct thing to do. Similar controversy surrounded organ donation. Today, more than 50 years after the first kidney transplant, organ donation has saved millions of lives across the globe. Stem cell research has even greater potential. And New Jersey is the best place to realize this potential. We are the medicine cabinet to the nation. We have a biotech cluster that is among the top five in America. Fifteen of the world’s largest pharmaceutical companies call New Jersey home. We have more scientists, engineers and technicians per capita than virtually any state in the country.

New Jersey is the natural place for stem cell research, and we must be willing to put state dollars behind it. A state investment will produce better health care, enhance our research and development industry and solidify New Jersey’s place at the forefront of medical technology.

I have proposed a $380 million investment in stem cell research, including $150 million for the construction of the New Jersey Stem Cell Research Institute. We want to attract the best researchers to New Jersey. We want to build a collaborative environment. And we want to extend beyond basic research into clinical research so ultimately our patients receive the most cutting edge treatments and best possible care.

I also proposed a $230 million ballot initiative for stem cell research grants. Our goal is to fund to the most promising research based on the best science. We will make sure the pool of eligible applicants is broad, from non-profits and universities to hospitals and the private sector. To ensure research is done ethically, we will establish an ethics panel to review proposals. And to make sure science—not politics—governs the award of grants, an independent panel of scientific experts will score applications. To ensure citizens of New Jersey benefit the state will share in five percent of the patent royalties. There has been a lot of legitimate discussion about whether now is the time to invest in stem cell research. But science and the potential benefits of this research, economically and on a human level cannot be put on hold until New Jersey’s financial stars align. The more we wait, the more we risk losing the best researchers to other states. We have a unique chance to be on the cutting edge of life saving research. We cannot let it pass us by.#

COMMENT ON THIS ARTICLE

Name:

Email:
Show email
City:
State:

 


 

 

Education Update, Inc.
All material is copyrighted and may not be printed without express consent of the publisher. © 2009.